Review Examines Effect Of Sofosbuvir-Based Direct-Acting Antivirals On Lower-Density Lipoprotein Levels In Patients With HCV

Infectious Disease Advisor (10/22, Gupta) reported, “Although the initial 4 weeks of treatment with a sofosbuvir (SOF)-based direct-acting antiviral (DAA) was associated with a significant increase in lower‑density lipoprotein (LDL) concentrations among p...